ReviewCancers2022
Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer.
Michal Grzmil et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCancers2022
Michal Grzmil et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.